Materials and methods for breast neurotization with nerve grafts

ABSTRACT

The subject invention pertains to materials and methods for performing breast neurotization with allogeneic or autologous nerves in breast surgeries, such as reconstructive breast surgery. Certain embodiments of the methods comprise harvesting and implanting one or more allogeneic or autologous intercostal nerves 10 to 12 to one or more of the patient&#39;s intercostal nerves 2 and/or 3.

CROSS-REFERENCE TO A RELATED APPLICATION

This application claims the benefit of U.S. Provisional Application Ser.No. 62/574,535, filed Oct. 19, 2017, the disclosure of which is herebyincorporated by reference in its entirety, including all figures, tablesand drawings.

BACKGROUND OF THE INVENTION

First descriptions of breast cancer can be found in the early medicalwritings of the ancient Greeks and Egyptians that date back to 480 B.C.However, modern treatment did not start until Halsted performed thefirst mastectomy in the 1880s. Since then, understanding and treatmentof breast cancer has evolved significantly. Today, post-mastectomybreast reconstruction is a fundamental element in breast cancer care.Although implant-based breast reconstruction is today's more commonreconstructive modality, long-term patient satisfaction is reportedlyhigher following autologous reconstruction. Hence, it is not surprisingthat many patients choose this reconstructive modality. Despitesignificant technical advances that have been made in autologousreconstruction, such as the development of perforator-based flaps thatminimize donor-site morbidity, abdominal wall weakness and donor-sitehernias remain significant complications.

Interestingly, the abundance of reports that focus on donor-sitemorbidity is contrasted by the paucity of studies focusing onrecipient-site outcomes beyond just flap survival. The importance ofbreast sensation cannot be overstated as it has a tremendous impact onpostoperative quality of life. In fact, the issue of post-mastectomyloss of sensation has recently been prominently addressed even in themainstream media. Hence, patients are increasingly inquiring aboutmodalities that not only reconstruct the breast but also restoresensation. A topic of much debate in this regard is breast neurotizationby virtue of flap reinnervation/neurotization at the time of transfer.

Breast neurotization is not a novel topic and has been discussed in theliterature since the early 1990s. Yet, since the introduction of sensateflaps for breast reconstruction, the debate has centered upon whethernerve coaptation is necessary for recovery of flap sensation or iscollateral ingrowth of the nerve fibers sufficient for meaningfulsensation. Available evidence suggests that restoration of sensation isimportant. Cases of involuntary thermal and mechanical injuries havebeen reported with a resultant negative impact on patient-rated qualityof life metrics. Multiple studies have shown that breast neurotizationof the donor flap nerves has resulted in more expeditious and improvedsensory recovery, improved patient satisfaction, and patient-reportedquality of life. On the other hand, several studies have failed todemonstrate such a difference in outcomes. An additional point of debatehas been whether the achievable outcomes following nerve coaptationjustify the additional operative time. Spontaneous reinnervation doesoccur to varying extents, but that sensory recovery of innervated flapsis superior, starts earlier, and gradually improves over time with ahigher chance of approaching normal sensation compared to non-innervatedflaps.

Notably, high heterogeneity and lack of standardization exist betweenthe studies, which prevents a meta-analysis of breast surgery outcomes.A specific area of concern is the lack of standardization of theneurotization procedure itself, varying from primary nerve repair to theuse of nerve conduits. Spiegel et al. evaluated sensory recovery ofautologous flaps and compared the use of a nerve conduit and directnerve coaptation to controls, i.e. spontaneous reinnervation. Theyconcluded that flap neurotization was superior to spontaneousinnervation, that the neurotization procedure did not prolong operativetime significantly, and that the use of a nerve conduit improved sensoryrecovery significantly over direct coaptation.

In certain conventional surgeries, return of sensation was observed, butfor conduit neurotized flaps the return of sensation was noted to beonly half of that of the contralateral non-operated breast skin and fordirect coaptation, the flap required four times higher pressure to reachsensibility. Although, there was return of sensation, meaningful sensoryrecovery following breast reconstruction is still desired.

One of the commonly used metrics to evaluate sensory outcome afterperipheral nerve surgery is the Medical Research Council (MRC) scale.The scale runs from S0 to S4 where S0 is no sensory recovery, S1 isrecovery of deep cutaneous pain, S2 is return of some superficialcutaneous pain and some degree of tactile sensibility, S3 is return ofsuperficial cutaneous pain and tactile sensibility without overresponse, S3+is return of superficial cutaneous pain and tactilesensibility with some 2-point discrimination recovery, and S4 iscomplete sensory recovery. The scale has been used to measure meaningfulrecovery which in some studies has been a defined as S3 and above.Secondly, it was noted that neurotization only required 10 to 15additional minutes of operative time. However, given the prior concernsof an insensate flap, the opportunity to restore sensation to thereconstructed breast should outweigh concerns related to potential caseprolongation. Lastly, they state that the nerve conduit used was a 40 mmnerve conduit. Lohmeyer et al. (2014, J Reconstr Microsurg.;30(4):227-34) performed a literature review for sensibility afterdigital nerve reconstructions with nerve conduits of varying lengths.They measured 2-point-discrimination and monofilament testing followingreconstruction with nerve conduits between 5 to 25 mm and found thatsensibility began to diminish after a conduit gap length of 6 mm.Monofilament testing was significantly worse after 12 mm, poorsensibility was noted after 15 mm, and over 20% of the patients in theirreview regained no sensibility. In light of these kind of reviews, theuse of tube conduits for breast neurotization or any other nerve surgerywith gaps larger than 6 mm is not advisable.

Breast neurotization is typically performed with autograft harvest.Autograft harvest involves harvesting autogenous nerves from abdominalsites and implanting the nerves into the recipient patient's breasttissue. Autograft harvest based breast neurotization requires longeroperation room procedures and increased risk of muscle denervation.Muscle denervation causes laxity, loss of muscle tone, poor aestheticoutcome, and increased risk of incisional hernia. Autograft harvest alsoinvolves loss of regenerative capacity because half of nerve diametergoes to muscle and produces dead ends. Therefore, surgical methods thatavoid problems associated with autograft harvest based breastneurotization are desirable.

BRIEF SUMMARY OF THE INVENTION

To overcome these shortcomings, the invention provides a standardizedand reproducible surgical procedures, and related materials, that allowfor conservation of the innervation to the rectus abdominis whileallowing for neurotization of the flap. In certain embodiments, thenerve allograft is used as a novel bridging material in breastneurotization, which overcomes shortcomings of direct coaptation,conduit, or autograft applications, and reflects on connector-assistednerve coaptation facilitating the nerve repair.

The subject invention provides materials and methods for performingbreast neurotization with nerve grafts in breast surgeries, such asreconstructive breast surgery. The methods of the invention mitigaterisks of conventional surgical methods and provide alternativeapproaches and mitigation plans.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows key anatomical landmarks for DIEP flap breastneurotization. Outlines of DIEP abdominal flap and post-mastectomy chestwall defect. Essential nerves (ICN1, ICN2, ICN3, ICN10, ICN11, ICN12),vascular structures (medial and lateral DIEA, internal mammary arteryand vein), and bony landmarks (ribs I, II, III) are shown.

FIG. 2A shows DIEP flap dissection in standard lateral to medialfashion. Schematic demonstrating typical positions of distal ends of thesensory components of respective intercostal nerves and expectedincision of rectus sheath lateral to intercostal nerves.

FIG. 2B shows intraoperative DIEP flap dissection with emphasis at thelateral raw perforators and lateral rectus border.

FIG. 3A shows exposure of the ICNs after the incision of anterior rectussheath and longitudinal rectus muscle fibers spread. Schematicrepresentation of the retrograde dissection of sensory component of theintercostal nerves (yellow) until joining the motor components (green)at an intramuscular sensory-motor Y junction. If medial row perforatorswere dominant and used for flap supply, lateral anterior rectus sheetfascial opening and rectus spread might be limited only to allow sensoryICN harvest.

FIG. 3B shows intraoperative view of a dissected sensory ICN componentas marked by the tip of the forceps.

FIG. 4A shows separation of sensory component of ICN11, just distal toY-junction with preserved motor component. Schematic showing resultingsensory nerve pedicle (yellow) and preserved motor component (green)with longitudinally dissected rectus muscle.

FIG. 4B shows intraoperative picture showing resultant sensory nervepedicle to be used for neurotization.

FIG. 5 shows dissection approach to third rib cartilage. Schematicshowing the resulting defect following mastectomy, pectoralis majormuscle is longitudinally spread and the perichondrium is incised andseparated circumferentially, in preparation for the third rib cartilagefor removal. Dashed vertical line is sternum.

FIG. 6A shows schematic drawing showing internal mammary artery and veinafter removal of the cartilage. ICN3 is available for use after carefulseparation from third rib cartilage and perichondrium.

FIG. 6B shows anatomical specimen dissection identifying ICN3 in itslocation along the inferior third rib cartilage.

FIG. 6C shows schematic showing ICN2 exposed by careful dissection fromperichondrium and the inferior border of second rib cartilage if dualinnervation with ICN3 is desired.

FIG. 6D shows specimen dissection identifying ICN2 in its location.

FIG. 7A shows vascular anastomosis of flap DIEA/DIEV to internal mammaryartery and vein. 7A. Schematic showing internal mammary artery and veinare dissected and separated inferiorly, which was then anastomosed tothe DIEP flap perforators. Yellow marked flap available donor nerves aresensory ICN11 and ICN12, while recipient chest nerves are INC2 and ICN3.

FIG. 7B shows intraoperative view of connected flap and chest vessels,and dissected ICN3 in preparation for nerve reconstruction.

FIG. 8A shows bridging of donor nerves to recipient nerves withprocessed human nerve allograft. Schematic showing tension free singlenerve neurotization with ICN11 and ICN3 with coaptation of the nervefacilitated by translucent porcine intestinal submucosa nerve connector,as alternative to direct suture.

FIG. 8B shows specimen illustration of single nerve breastneurotization.

FIG. 8C shows schematic showing tension free dual nerve neurotizationwith ICN11 and ICN12 connected to ICN2 and ICN3, respectively.

FIG. 8D shows specimen illustration of dual nerve breast neurotization.

FIG. 9A shows traditional dissection and separation of donor intercostalnerve. Schematic showing the donor pedicle that consists of both sensory(yellow) and motor (green) components that were dissected out of therectus abdominis muscle (original position of pedicle illustrated bydashed yellow line).

FIG. 9B shows intraoperative picture of traditional dissection of donorintercostal nerve that contains both sensory and motor components.

DETAILED DESCRIPTION OF THE INVENTION

The invention provides surgical methods for implanting autogenous orallogeneic nerves into a patient's breast. Such implantation inducesbreast neurotization of the breast tissue in the patient that hasundergone or is undergoing a breast surgery, such as mastectomy orbreast reconstruction surgery.

In preferred embodiments, the methods provided herein allow forneurotization of the entire breast tissue flap via an autogenous orallogeneic nerve graft. The methods comprise implanting nerve tubes,including synthetic nerve tubes, allogeneic nerves, or autogenous nervesinto breast flap.

Deep inferior epigastric perforator (DIEP) flap breast reconstructionshave been known to have limited return of sensation at the recipientsite, and potentially cause abdominal bulge and wall weakness at thedonor site. Breast neurotization or reinnervation of reconstructedbreast flaps have been shown to have protective effects againstmechanical or thermal injuries as well as positive effects on apatient's quality of life. However, simultaneous breast neurotization ofthe flap area is yet to be a standardized component in breastreconstruction procedures after mastectomies. In addition, currentclinical breast neurotization data point to the lack of a standardizedoperative approach, a standard nerve gap bridging medium, and a paucityin homogenous data for clinical sensory recovery outcomes.

With these issues in mind, certain embodiments of the invention providesurgical techniques that minimize abdominal wall morbidities, provide astandardized breast neurotization technique, and increase the chances ofmeaningful sensory recovery by utilizing the human processed nerveallograft as the preferred nerve gap bridging material. This operativetechnique is unique in the use of the nerve allograft for breastneurotization and selective use of only the sensory component of theflap, while preserving the rectus abdominis motor innervation.

Processed nerve allografts have been shown in clinical studies to beeffective in bridging gap lengths up to 70 mm, with superior meaningfulsensory recovery outcomes compared to hollow tube nerve conduits, andcomparable to nerve autografts without the additional operativemorbidities. The surgical methods of the invention can be customized toenable single or dual nerve breast neurotization and this novel approachperforms favorably compared to conduit or autograft neurotization. Thematerials and methods of the subject invention enable surgeons to applya standardized and reproducible breast neurotization surgery, furtheroptimizing chances of meaningful sensory recovery.

Breast neurotization is an important component of breast reconstruction.The invention demonstrates the importance of taking only the sensorybranch and preserving the motor branch at the donor site. Thisselectivity prevents aberrant nerve regeneration of the recipientsensory nerve into a blind motor stump thus optimizing sensory outcomes.This also provides anatomical justification for why sensation recoveryin the autograft-neurotized breasts is less than expected.

Further, the technical aspect in selectively dissecting and extractingonly the sensory components of ICN11 and/or ICN12 along with theselective use of medial row perforators minimizes the risk of rectusabdominis denervation and the associated morbidities.

The identification and utilization of reliable predictable landmarksallows the surgical methods of the invention to be consistentlyrepeated.

Hollow tube nerve conduits alone are not suitable for breastneurotization and the human processed nerve allograft based onnon-breast neurotization studies would be the ideal and most promisingbridging medium. In addition, allograft nerve reconstructions comparefavorably to nerve autograft outcomes but without the additional donorsite associated morbidities. Thus, nerve allografts are a vital elementfor this technique.

Lastly, the utilization of the connector-assisted nerve coaptationeliminates misalignment risks. By incorporating the processed nerveallograft in the surgical methods, the invention provides standardizedbreast neurotization during breast reconstruction, minimized abdominalwall related morbidities, and improved meaningful sensory recovery andthus quality of life in breast reconstruction patients.

In certain embodiments, the invention provides a surgical method forbreast neurotization. The method comprises implanting an allogeneic orautologous nerve to the patient's breast flap. In some embodiments, theallogeneic or autologous nerve is obtained from an intercostal nerve(ICN), particularly, ICN10, ICN11, or ICN12.

In a single allograft, an allogeneic or autologous ICN10, ICN11, orICN12 is harvested and implanted to the patient's ICN2 or ICN3. Forexample, an allogeneic or autologous nerve from ICN10, ICN11, and ICN12is harvested and implanted to one of the patient's ICN2 or ICN3. Forexample, ICN10 or ICN11 can be harvested and implanted to ICN2 or ICN3.Alternatively, ICN11 or ICN12 can be harvested and implanted to ICN2 orICN3.

In a dual graft, two nerves from ICN10, ICN11, or ICN12 are harvestedand implanted to the patient's ICN2 and ICN3. For example, two nervesfrom ICN10, ICN11, and ICN12 are harvested and each is implanted to oneof the patient's ICN2 and ICN3. Alternatively, ICN10 and ICN11 can beharvested and implanted to ICN2 and ICN3, respectively. Similarly, ICN11and ICN12 can be harvested and implanted to ICN2 and ICN3, respectively.

In certain embodiments, only the sensory portion of the nerve ICN10,ICN11, or ICN12 is harvested and implanted in the sensory portion of thenerve ICN2 or ICN3. In certain such embodiments, only the sensoryportions of two of the nerves ICN10, ICN11, and ICN12 are harvested andeach is implanted in the sensory portion of the nerve ICN2 or ICN3.

Harvesting only the sensory portions of the nerves from ICN10, ICN11, orICN12 retains the motor innervation in the rectus abdominis. Byconserving the motor component of the lateral intercostal nerves to thelateral rectus, abdominal wall morbidity is minimized.

In further embodiments, processed nerve allograft is used as thebridging material in implantation of the donor nerve. Alternatively,nerve tubes can be used as the bridging material in the implantation ofthe donor nerve.

The nerve tubes or processed nerve allografts used in certainembodiments of the invention can contain neurotrophic growth factorsthat stimulate nerve regeneration. Inclusion of such growth factorsfacilitates innervation of the flap tissue. Such growth factors includebrain-derived neurotrophic factor (BDNF), glial cell-derivedneurotrophic factor (GDNF), neurotrophic factor (NGF), neutrophin-3(NT-3), ciliary neurotrophic factor (CNTF), and leukemia inhibitoryfactor (LIF).

Certain examples of nerve regeneration tubes are described in the U.S.Pat. Nos. 9,687,592; 9,108,042; 9,017,714; 8,741,328; 8,632,844;8,603,512; 7,842,304; 7,615,063; 7,135,040; 6,589,257; 6,090,117;5,656,605; and 4,778,467. Each of these patents is incorporated hereinby reference in its entirety.

Further embodiments of the invention provide a set of nerve graftscomprising at least two nerve grafts prepared from ICN10, ICN11, andICN12. In some embodiments the set comprises at least two nerve graftsare prepared from ICN10, ICN11, and ICN12 obtained from one donor. Inother embodiments, the set comprises at least two nerve grafts preparedfrom ICN10, ICN11, and ICN12 obtained from different donors. A set ofnerve grafts disclosed herein can be used in a suitable surgery, forexample, breast neurotization surgery described herein.

Each of the nerve grafts in the set of nerve grafts of the invention canbe processed to prepare nerve grafts suitable for implantation in arecipient. Certain techniques of processing nerves to produce nervegrafts are described in U.S. Pat. Nos. 9,572,911; 9,402,868; 7,851,447;and 6,972,168. Each of these patents is incorporated herein by referencein its entirety.

Definitions:

An autologous graft is an organ, a tissue, or a part thereof obtainedfrom a first site from a subject for implantation to a second site inthe subject.

An allogeneic graft is an organ, a tissue, or a part thereof obtainedfrom a first individual for implantation to a second individual of thesame species as the first individual.

Neurotization refers to re-innervation of nerves in a portion of a bodythat has lost its innervation through irreparable damage to its nerve.Neurotization does not require a complete return of the sensation,sensory, or motor properties of the portion of the body that lost itsinnervation.

EXAMPLE 1—SURGICAL METHODS OF THE INVENTION

Preoperative markings were made with the patient standing. The patientis subsequently brought to the operating room and placed in supineposition with bilateral arms abducted. The abdominal flap (FIG. 1) isdissected in a standard lateral to medial fashion until lateral rowperforators and associated intercostal nerves are exposed (FIGS. 2A-2B).The anterior rectus sheath is incised craniocaudally along the lateralrow perforators to expose the rectus abdominis muscle, lateralperforator vessels, and intercostal nerves (ICN) 11 and ICN12 (FIGS.3A-3B).

Upon identification of ICN11 and/or ICN12, next to the lateral row ofvascular perforators, standard retrograde dissection of the sensorybranch of the intercostal nerve ICN11 and/or ICN12 is traced until asensory-motor Y-junction is encountered. While this may be seen intra-or retro-muscularly, the exposure can be accomplished by longitudinalspread rather than transection of the rectus muscle fibers, thuspreserving its integrity.

Care must be exercised to protect the lateral row vascular perforatorsin the case these are planned to be incorporated into a DIEP flap.However, with this technique if the medial row vascular perforators areused as a dominant vascular supply to the flap, vertical anterior rectusfascial split along lateral perforators and rectus muscle spread mightbe minimized and limited to only allow ICN sensory graft harvest,without extensive fascial opening or dissection.

In addition to the retrograde dissection of sensory ICN11 and/or ICN12branch, the motor component is preserved to prevent denervation of therectus abdominis muscle. The motor preservation is performed even whenthe lateral perforators are chosen as the dominant vascular supply. Thisis accomplished by harvesting the sensory component just distal to thesensory-motor Y-junction, leaving the motor innervation to the lateralrectus abdominis muscle intact (FIGS. 4A-B).

The inclusion of one or two ICNs depends on whether a single or dualinnervation of the flap is desired. Once sensory ICN branch(es) aredissected and divided, the remainder of the DIEP flap vasculardissection is completed, leaving the flap perfused until chestdissection is complete.

Following mastectomy, the pectoralis major muscle fibers arelongitudinally split over the third costal cartilage to expose theperichondrium of the third rib. The perichondrium is incised andsubperichondrial dissection performed, followed by the removal of thethird costal cartilage. Next, the posterior perichondrium is carefullyincised and a lateral-to-medial dissection is performed until theinternal mammary vessels are visualized (FIG. 5).

It is important to recognize that the ICN3 runs along the inferiorborder of third rib (FIGS. 6A-6B). Once identified under theperichondrium and along the inferior rib border, it is preserved, tracedmedially, then divided, and reflected laterally for subsequent nervecoaptation. If dual innervation is desired, then the ICN2 can be foundwithin the upper pole of the surgical field, under the perichondrium,just inferior to and along the second rib border (FIGS. 6C-6D).

The flap is then disconnected from the donor-site and brought to thechest. Microsurgical arterial and venous anastomosis is performed instandard fashion (FIGS. 7A-7B). To preserve the flap's full arch ofrotation required to inset the flap, and to ensure tension-free nerverepair, the nerve coaptation is performed using a 1-2 mm×50 or 1-2 mm×70processed human nerve allograft (Avance® Nerve Graft, AxoGen, AlachuaFla.) to bridge the gap. The interposing nerve allograft is thenmicrosurgically connected to chest recipient and flap donor nerve endsvia direct suture, alternatively, proximal and distal coaptation can befacilitated with a translucent and porous porcine intestinal submucosanerve connector (AxoGuard Nerve Connector, AxoGen, Alachua Fla.) (FIG.8A,B). The flap is then inset and the abdominal donor site closed instandard fashion, thus, completing the neurotized DIEP flap breastreconstruction.

EXAMPLE 2—ADVANTAGES PROVIDED BY THE SURGICAL METHODS OF THE INVENTION

Homogeneity of a surgical approach is critical to reliably comment onthe efficacy of a procedure or a procedural concept such as breastneurotization. Hence, establishing a standardized surgical technique isimportant to facilitate future homogenous comparative analysis. A clearunderstanding of the principles of nerve surgery as well as expertiseregarding the characteristics of available reconstructive choices likenerve conduits, autografts, and processed nerve allografts are criticalfor successful execution of this proposed procedure.

Standard treatment of nerve injuries consists of tensionless primaryrepair whenever possible. However, if primary repair is not possible,then bridging materials are utilized, which include nerve autografts,tube conduits, and processed nerve allografts. The nerve gap encounteredwith breast neurotization typically measures between 50 to 70 mm, thus,far exceeding the length that is recommended for reconstruction withnerve conduits. While nerve autografts have traditionally been preferredwhen reconstructing extremity nerve defects, they are associated withdonor-site complications including additional incisions, wound healingissues, painful neuroma formation, or bulge/incisional hernias if rectusmuscle is denervated.

By using a processed nerve allograft, donor-site complicationsassociated with the harvest of nerve autografts can be avoided.Processed nerve allograft is an extracellular matrix (ECM) scaffoldingcreated from donated human peripheral nerve tissue that has beendecellularized, pre-degenerated, and sterilized, which results in acell-free microstructural architecture with the protein composition ofnerve tissue. The decellularization of the allograft significantlyreduces the risk of immune rejection issues, thus eliminating the needfor immunosuppressive therapy. The resultant allograft is composed ofbundles of endoneurial microtubes, contained within the original nerve'sfascicle and epineurial scaffold, which is comprised of ECM proteins(laminin, fibronectin, and glycosaminoglycans) that provide naturalaxonal growth cues for guided regrowth, otherwise not found in hollowtube conduits.

The first critical element of the donor site dissection depends onidentification and perseveration of the donor intercostal nerves.Cadaveric studies have found that the rectus abdominis is innervated bynerves from the rectus sheath plexus that run parallel with the mostlateral branch of the DIEA before running with arterial perforators intothe rectus abdominis and anterior abdominal wall. Thus, the lateralbranch of the DIEA and lateral row perforators are intimately related tothe intercostal nerves that innervate the rectus abdominis muscle andany damage incurred to these structures during DIEP flap harvest wouldcontribute to the previously mentioned donor-site morbidity of abdominalwall weakness, abdominal bulge, or hernia. Although DIEP flap aims toovercome TRAM (transversus rectus abdominis muscle) flap shortcomings,the reported incidence of abdominal bulge or incisional herniaoccurrence after a DIEP flap is still 3-5%. By conserving the motorcomponent of the lateral intercostal nerves to the lateral rectus,abdominal wall morbidity should be minimized even further.

An equally important element of the donor site dissection is themethodology by which the sensory nerves are exposed and harvested.Routinely, the motor branch is often sacrificed and taken in conjunctionwith the sensory component during the flap dissection and/or autograftharvest. This approach elongates the extracted nerve by approximately10-12 cm in length, but in addition to risking rectus abdominisdenervation there is another common overlooked risk in utilizing acombined sensorimotor nerve (FIGS. 9A-9B). The risk is that as therecipient nerve begins to regenerate distally and joins with the donornerve, the sensory branch may regenerate into the clipped motorcomponent with only up to 50% of fibers feeding the sensory branch. Thisis expected to decrease the degree of sensory recovery. To address thisrisk, using only the sensory components of ICN11 and/or ICN12 isproposed. To extract only the sensory component while preserving themotor branches, the cutaneous sensory nerves will be followed proximallyin a retrograde fashion to the Y-junction where it joins the motorcomponent before continuing proximally as a mixed nerve. The sensorycomponent is harvested at the Y-junction, fully preserving the motorbranches going into the lateral rectus abdominis. The pure sensory nervepedicle is relatively short and therefore, a processed nerve allograftcan be used if necessary to bridge the gap (FIGS. 8). This approach issuggested to provide a proper anatomical platform aiming to optimize thechances of neurotization and meaningful recovery, while also fullypreserving rectus abdominis innervation.

Also equally important are the critical elements at the recipient site,which depend on the careful dissection and identification of ICN2 and/orICN3. ICN3 is the recipient nerve of choice, but ICN2 can also bereliably found in the anterior chest within the same surgical field.

The processed nerve allograft overcomes the short nerve pedicle from theDIEP flap and allows for a tension-free nerve coaptation. Alternatively,if the thoracodorsal vascular system is chosen as the vascular supply,then the lateral ICN4 can be used along the anterior axillary line.

Otherwise ICN4 can be used with the internal mammary vascular system,because there are two pivoting points, one vascular medially, and theother nerve laterally, which might affect the extent of flap rotationand inset. In addition, erogenous nipple/areola sensory innervation isprimarily carried by the lateral branches of ICN4 and the implicationsof using a nerve with these functions for breast neurotization at thistime is not well understood.

Thus, if ICN4 is used to neurotize the entire breast flap, then theremay be sequelae related to overstimulation. Taking this intoconsideration, as well as the fact that lateral branches of ICN4 areusually transected at the level of the chest wall musculature in theprocess of mastectomy, these branches are mostly unavailable forneurotization, unless specifically dissected and preserved before orduring the mastectomy.

Due to aforementioned concerns related to ICN4, ICN4 may not bepreferred as a dominant recipient for breast neurotization.

Lastly, as an alternative to standard direct suture allograft-nervecoaptation, connector-assisted microsurgical coaptation of theinterposing nerve allograft between the flap donor and chest recipientnerves, may facilitate growth across the coaptation site withoutfascicular misalignment or undue axonal escape.

The surgical methods of the invention revolutionize breastreconstruction by offering a reliable, reproducible, and effectiveneurotization procedure.

I claim:
 1. A surgical method comprising implanting at least one nervegraft comprising: (i) one or more allogenic nerve grafts and/or (ii) oneor more autologous nerve grafts, into a patient's breast, wherein theone or more allogeneic nerve grafts and/or one or more autologous nervegrafts comprise one or more intercostal nerve (ICN) grafts.
 2. Thesurgical method of claim 1, wherein the patient has received or isundergoing a breast surgery.
 3. The surgical method of claim 2, whereinthe breast surgery is one or more of a mastectomy or a breastreconstruction surgery.
 4. The surgical method of claim 1, wherein theone or more ICN grafts comprise one or more of ICN10, ICN11, or ICN12.5. The surgical method of claim 4, wherein one or more of the ICN10,ICN11, or ICN12 are implanted to one or more of the patient's ICN2,ICN3, or ICN4.
 6. The surgical method of claim 5, wherein two of theICNs from ICN10, ICN11, or ICN12 are implanted to two of the patient'sICN2, ICN3, or ICN4.
 7. The surgical method of claim 5, wherein theICN10 and ICN11 are implanted to the patient's ICN2 and ICN3,respectively.
 8. The surgical method of claim 5, wherein the patient'sICN11 and ICN12 are implanted to the patient's ICN2 and ICN3,respectively.
 9. The surgical method of claim 5, wherein only a sensoryportion of one or more of the ICN10, ICN11, or ICN12 is implanted to asensory portion of one or more of the patient's ICN2, ICN3, or ICN4. 10.The surgical method of claim 5, further comprising: harvesting a sensoryportion of the ICN10, ICN11, or ICN12 at a Y-junction where the sensoryportion of the ICN10, ICN11, or ICN12 joins a motor portion of theICN10, ICN11, or ICN12, respectively.
 11. The surgical method of claim5, wherein the one or more of the ICN10, ICN11, or ICN12 are harvestedfrom and implanted in the same patient.
 12. The surgical method of claim4, wherein a motor portion of the ICN10, ICN11, or ICN12 is left intactin the donor site.
 13. The surgical method of claim 1, wherein abridging material is used to bridge a gap in the implantation of a donornerve.
 14. The surgical method of claim 13, wherein the bridgingmaterial comprises one or more of a processed nerve allograft, a nerveauto graft, or a nerve tube.
 15. The surgical method of claim 14,wherein the bridging material further comprises a neurotrophic growthfactor configured to stimulate nerve regeneration when the bridgingmaterial is one or more of the nerve auto graft or the nerve tube. 16.The surgical method of claim 15, wherein the neurotrophic growth factorcomprises one or more of brain-derived neurotrophic factor (BDNF), glialcell-derived neurotrophic factor (GDNF), neurotrophic factor (NGF),neutrophin-3 (NT-3), ciliary neurotrophic factor (CNTF), or leukemiainhibitory factor (LIF).
 17. A set of nerve grafts comprising at leasttwo nerve grafts prepared from intercostal nerves, wherein the set ofnerve grafts comprises at least two nerve grafts prepared from one ormore of ICN10, ICN11, or ICN12 obtained from one or more sources.